Saltar al contenido
Merck
  • Generation of eye field/optic vesicle-like structures from human embryonic stem cells under two-dimensional and chemically defined conditions.

Generation of eye field/optic vesicle-like structures from human embryonic stem cells under two-dimensional and chemically defined conditions.

In vitro cellular & developmental biology. Animal (2014-11-28)
Maryam Parvini, Kazem Parivar, Fatemeh Safari, Mahdi Tondar
RESUMEN

Despite the enormous progress in studying retinal cell differentiation from human embryonic stem cells (hESCs), none of the reported protocols have produced a cost-effective eye field cells with the capability to further differentiate into retinal derivatives. In this study, by drawing chemicals on our four-step differentiation strategy, we demonstrated the ability of hESCs in assembling such qualifications to follow human retinogenesis in a serum- and feeder-free adherent condition. Two-dimensional (2D) populations of eye field cells arose within early forebrain progeny upon hESCs differentiation. Gene expression analysis showed that the treatment of hESCs with a combination of selected small molecules (SMs) gave rise to the higher expressions of eye field-specific genes, PAX6, RX, and SIX3. Thereafter, a subset of cells gained the transient features of advancing retinal differentiation, including optic vesicle (OV)-like structures, which expressed MITF and CHX10 in a manner imitated in vivo human retinal development. The competency of derived cells in differentiation to retinal derivatives was further investigated. The gene analysis of the cells showed more propensity for generating retinal pigment epithelial (RPE) than neural retina (NR). The generation of OV-like structures in 2D cultures can shed light on molecular events governing retinal specification. It can also facilitate the study of human retinal development.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Dodecilsulfatosódico, BioReagent, suitable for electrophoresis, Molecular Biology, ≥98.5% (GC)
Sigma-Aldrich
Ácido retinoico, ≥98% (HPLC), powder
Sigma-Aldrich
Dodecilsulfatosódico, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
DL-Ditiotreitol solution, BioUltra, Molecular Biology, ~1 M in H2O
Sigma-Aldrich
Dodecilsulfatosódico, ACS reagent, ≥99.0%
Sigma-Aldrich
Sodium dodecyl sulfate solution, BioUltra, Molecular Biology, 10% in H2O
Supelco
DL-Ditiotreitol solution, 1 M in H2O
Sigma-Aldrich
Dodecilsulfatosódico, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Gel ECM from Engelbreth-Holm-Swarm murine sarcoma, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
Dodecilsulfatosódico, BioUltra, Molecular Biology, ≥99.0% (GC)
Sigma-Aldrich
Sodium selenite, 99%
Sigma-Aldrich
Sodium dodecyl sulfate solution, BioUltra, 20% in H2O
Sigma-Aldrich
Nicotinamide, ≥99.5% (HPLC)
Sigma-Aldrich
Sodium selenite, BioReagent, suitable for cell culture, ≥98%
Supelco
Dodecilsulfatosódico, dust-free pellets, suitable for electrophoresis, Molecular Biology, ≥99.0% (GC)
Sigma-Aldrich
Progesterone, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Sodium selenite, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
Supelco
Dodecilsulfatosódico, suitable for ion pair chromatography, LiChropur, ≥99.0%
Supelco
Nicotinamide, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Bromophenol Blue, ACS reagent
Sigma-Aldrich
Nicotinamide, ≥98% (HPLC), powder
Sigma-Aldrich
Progesterone, ≥99%
Sigma-Aldrich
1,4-Diaminobutano, 99%
Sigma-Aldrich
Bromophenol Blue, titration: suitable
Sigma-Aldrich
Dodecilsulfatosódico, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
Dodecilsulfatosódico, ≥98.0% (GC)
Sigma-Aldrich
XAV939, ≥98% (HPLC)
Sigma-Aldrich
Dodecilsulfatosódico, 92.5-100.5% based on total alkyl sulfate content basis
Supelco
1,4-Diaminobutano, analytical standard